Abbott statement on the FDA Advisory Committee recommendations on fenofibric acid
19 May 2011 | By Abbott
Results of the ACCORD Lipid study...
List view / Grid view
Abbott Laboratories is an American worldwide healthcare company. With headquarters in Lake Bluff, Illinois, it has 94,000 employees and operates in more than 150 countries.
The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; it eventually grew to also sell research-based drugs, medical devices, diagnostics, and nutritional products. It split off the research-based pharmaceuticals into Abbvie in 2013. In 2015, revenues were $20.4 billion.
Abbott has a broad range of branded generic pharmaceuticals, medical devices, diagnostics, and nutrition products. The company’s in-vitro diagnostics business performs immunoassays and blood screening. Its medical tests and diagnostic instrument systems are used worldwide by hospitals, laboratories, blood banks, and physician offices to diagnose and monitor diseases such as HIV, hepatitis, cancer, heart failure and metabolic disorders, as well as assess other indicators of health. In 1985, the company developed the first HIV blood-screening test.
19 May 2011 | By Abbott
Results of the ACCORD Lipid study...
18 May 2011 | By Abbott
Abbott has received approval from the FDA to market its RealTime PCR test for measuring the viral load of hepatitis C...
11 May 2011 | By Fleming Europe
Network with c-level industry leaders from AstraZeneca, Sanofi Aventis, Roche, Novartis, Baxter, Pfizer & Abbott...
6 May 2011 | By Abbott
Abbott announced that the FDA approved the RX ACCULINK® Carotid Stent System...
19 April 2011 | By Abbott
Abbott announced that Miles D. White has been elected to the American Academy of Arts and Sciences...
11 April 2011 | By GDS International
Every other industry is getting on the social media bandwagon. But could social media actually prove beneficial to the world of pharma?...
23 February 2011 | By Johnson & Johnson
Centocor received a decision from the Court of Appeals overturning a 2009 federal court jury verdict that awarded the company $1.8 billion...
11 February 2011 | By Abbott
Abbott are streamlining its UK supply chain route for pharmaceuticals, nutritionals and diabetes products...
3 January 2011 | By AstraZeneca
AstraZeneca has notified Abbott that it will discontinue the development of CERTRIAD on 22 January 2011...
22 November 2010 | By Abbott
Abbott announced positive results from a Phase 2 dose-ranging study of atrasentan...
8 April 2010 | By
Paula Staples joins Owen Mumford as Global Head of Quality reporting directly to Managing Director, Jarl Severn.
European Pharmaceutical Review brings you a comprehensive guide to the current developments and possible future innovations within Process Analytical Technologies...